Skip to main content

Medical Subject Headings

Search from vocabulary

Content language

Concept information

... > Complex Mixtures > Biological Products > Vaccines > Vaccines, Subunit > Vaccines, Acellular > mRNA Vaccines > 2019-nCoV Vaccine mRNA-1273
... > Complex Mixtures > Biological Products > Vaccines > Vaccines, Synthetic > Nucleic Acid-Based Vaccines > mRNA Vaccines > 2019-nCoV Vaccine mRNA-1273
... > Biological Factors > Antigens > Vaccines, Synthetic > Nucleic Acid-Based Vaccines > mRNA Vaccines > 2019-nCoV Vaccine mRNA-1273
... > Amino Acids, Peptides, and Proteins > Proteins > Recombinant Proteins > Vaccines, Synthetic > Nucleic Acid-Based Vaccines > mRNA Vaccines > 2019-nCoV Vaccine mRNA-1273
... > Complex Mixtures > Biological Products > Vaccines > Viral Vaccines > COVID-19 Vaccines > 2019-nCoV Vaccine mRNA-1273

Preferred term

2019-nCoV Vaccine mRNA-1273  

Type

  • Topical Descriptor

Broader concept

Entry terms

  • COVID 19 Vaccine Moderna
  • COVID-19 Vaccine Moderna
  • COVID-19 Vaccine, Moderna
  • Moderna COVID 19 Vaccine
  • Moderna COVID-19 Vaccine
  • Moderna, COVID-19 Vaccine
  • Moderna COVID 19 Vaccine RNA
  • Moderna COVID-19 Vaccine RNA
  • mRNA 1273
  • mRNA-1273
  • Vaccine, Moderna COVID-19

Scope note

  • mRNA vaccine against SARS-CoV-2, developed by Moderna.

History note

  • 2022(2021)

In other languages

  • 2019-nCov-mRNA-1273-rokote

    Finnish

  • elasomeraani
  • Modernan 2019-nCov-mRNA-1273-rokote
  • Modernan mRNA-1273-Covid-19-rokote
  • Modernan mRNA-1273-koronarokote
  • Modernan mRNA-1273-rokote uutta koronavirusta vastaan
  • Modernan Spikevax
  • Spikevax
  • 2019-nCoV Vaccin mRNA-1273

    Swedish

  • Modernavaccinet

URI

http://www.yso.fi/onto/mesh/D000090983

Download this concept:

RDF/XML TURTLE JSON-LD Created 7/9/21, last modified 5/22/23